256 related articles for article (PubMed ID: 7498987)
1. Angiotensin-(1-7) potentiates the hypotensive effect of bradykinin in conscious rats.
Paula RD; Lima CV; Khosla MC; Santos RA
Hypertension; 1995 Dec; 26(6 Pt 2):1154-9. PubMed ID: 7498987
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-(1-7) potentiates responses to bradykinin but does not change responses to angiotensin I.
Greco AJ; Master RG; Fokin A; Baber SR; Kadowitz PJ
Can J Physiol Pharmacol; 2006 Nov; 84(11):1163-75. PubMed ID: 17218981
[TBL] [Abstract][Full Text] [Related]
3. Potentiation of the hypotensive effect of bradykinin by short-term infusion of angiotensin-(1-7) in normotensive and hypertensive rats.
Lima CV; Paula RD; Resende FL; Khosla MC; Santos RA
Hypertension; 1997 Sep; 30(3 Pt 2):542-8. PubMed ID: 9322979
[TBL] [Abstract][Full Text] [Related]
4. Potentiation of the hypotensive effect of bradykinin by angiotensin-(1-7)-related peptides.
Paula RD; Lima CV; Britto RR; Campagnole-Santos MJ; Khosla MC; Santos RA
Peptides; 1999; 20(4):493-500. PubMed ID: 10458520
[TBL] [Abstract][Full Text] [Related]
5. Evidence for Mas-mediated bradykinin potentiation by the angiotensin-(1-7) nonpeptide mimic AVE 0991 in normotensive rats.
Carvalho MB; Duarte FV; Faria-Silva R; Fauler B; da Mata Machado LT; de Paula RD; Campagnole-Santos MJ; Santos RA
Hypertension; 2007 Oct; 50(4):762-7. PubMed ID: 17664388
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effect of angiotensin-(1-7) on bradykinin arteriolar dilation in vivo.
Oliveira MA; Fortes ZB; Santos RA; Kosla MC; De Carvalho MH
Peptides; 1999; 20(10):1195-201. PubMed ID: 10573291
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-(1-7) antagonist A-779 attenuates the potentiation of bradykinin by captopril in rats.
Maia LG; Ramos MC; Fernandes L; de Carvalho MH; Campagnole-Santos MJ; Souza dos Santos RA
J Cardiovasc Pharmacol; 2004 May; 43(5):685-91. PubMed ID: 15071356
[TBL] [Abstract][Full Text] [Related]
8. Potentiation of bradykinin by angiotensin-(1-7) on arterioles of spontaneously hypertensive rats studied in vivo.
Fernandes L; Fortes ZB; Nigro D; Tostes RC; Santos RA; Catelli De Carvalho MH
Hypertension; 2001 Feb; 37(2 Pt 2):703-9. PubMed ID: 11230360
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-(1-7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide.
Li P; Chappell MC; Ferrario CM; Brosnihan KB
Hypertension; 1997 Jan; 29(1 Pt 2):394-400. PubMed ID: 9039133
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-(1-7) contributes to the antihypertensive effects of blockade of the renin-angiotensin system.
Iyer SN; Ferrario CM; Chappell MC
Hypertension; 1998 Jan; 31(1 Pt 2):356-61. PubMed ID: 9453328
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-(1-7) potentiates the coronary vasodilatatory effect of bradykinin in the isolated rat heart.
Almeida AP; Frábregas BC; Madureira MM; Santos RJ; Campagnole-Santos MJ; Santos RA
Braz J Med Biol Res; 2000 Jun; 33(6):709-13. PubMed ID: 10829099
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-(1-7) induces bradykinin-mediated hypotensive responses in anesthetized rats.
Abbas A; Gorelik G; Carbini LA; Scicli AG
Hypertension; 1997 Aug; 30(2 Pt 1):217-21. PubMed ID: 9260983
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin(1-7) potentiates bradykinin-induced vasodilatation in man.
Ueda S; Masumori-Maemoto S; Wada A; Ishii M; Brosnihan KB; Umemura S
J Hypertens; 2001 Nov; 19(11):2001-9. PubMed ID: 11677365
[TBL] [Abstract][Full Text] [Related]
14. Endogenous angiotensin II and bradykinin delay and attenuate the hypotension after N-type calcium channel blockade in conscious rabbits.
Whorlow SL; Angus JA; Wright CE
J Cardiovasc Pharmacol; 1998 Dec; 32(6):951-61. PubMed ID: 9869501
[TBL] [Abstract][Full Text] [Related]
15. Evidence that prostaglandins mediate the antihypertensive actions of angiotensin-(1-7) during chronic blockade of the renin-angiotensin system.
Iyer SN; Yamada K; Diz DI; Ferrario CM; Chappell MC
J Cardiovasc Pharmacol; 2000 Jul; 36(1):109-17. PubMed ID: 10892668
[TBL] [Abstract][Full Text] [Related]
16. Local inhibition of converting enzyme and vascular responses to angiotensin and bradykinin in the human forearm.
Benjamin N; Cockcroft JR; Collier JG; Dollery CT; Ritter JM; Webb DJ
J Physiol; 1989 May; 412():543-55. PubMed ID: 2557432
[TBL] [Abstract][Full Text] [Related]
17. Effect of chronic angiotensin converting enzyme inhibition on angiotensin I and bradykinin metabolism in rats.
Stanziola L; Greene LJ; Santos RA
Am J Hypertens; 1999 Oct; 12(10 Pt 1):1021-9. PubMed ID: 10560789
[TBL] [Abstract][Full Text] [Related]
18. Do the cardiovascular effects of angiotensin-converting enzyme (ACE) I involve ACE-independent mechanisms? new insights from proline-rich peptides of Bothrops jararaca.
Ianzer D; Santos RA; Etelvino GM; Xavier CH; de Almeida Santos J; Mendes EP; Machado LT; Prezoto BC; Dive V; de Camargo AC
J Pharmacol Exp Ther; 2007 Aug; 322(2):795-805. PubMed ID: 17475904
[TBL] [Abstract][Full Text] [Related]
19. Hypotensive and natriuretic effects of RB 105, a new dual inhibitor of angiotensin converting enzyme and neutral endopeptidase in hypertensive rats.
Gonzalez Vera W; Fournié-Zaluski MC; Pham I; Laboulandine I; Roques BP; Michel JB
J Pharmacol Exp Ther; 1995 Jan; 272(1):343-51. PubMed ID: 7815350
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme inhibition, anti-hypertensive activity and hemodynamic profile of trandolapril (RU 44570).
Brown NL; Badel MY; Benzoni F; Zanirato J; Vincent JC; Fichelle J; Worcel M
Eur J Pharmacol; 1988 Mar; 148(1):79-91. PubMed ID: 3383998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
